Excell Research, 3998 Vista Way — Oceanside, California

Excell Research, 3998 Vista Way is a clinical research site located in Oceanside, California, United States 92056.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Excell Research, 3998 Vista Way has participated in 1 clinical trials.

Therapeutic areas: Migraine Headache.

Sponsors: Impel Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oceanside

Browse all research sites in California · View every site in Oceanside

• Naval Hospital Camp Pendelton
• Naval Hospital Campe Pendleton
• Sharp Memorial Hospital
• Naval Hospital Camp Pendleton
• Excell Research
• Dermatology Specialists
• Research Site
• North County Clinical Research
• Pfizer Investigational Site
• Alkermes Investigational Site
• Novartis Investigative Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Excell Research, 3998 Vista Way?

Excell Research, 3998 Vista Way has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Excell Research, 3998 Vista Way conducted?

Excell Research, 3998 Vista Way has 1 clinical trials on record. Their work covers Migraine Headache.

Is Excell Research, 3998 Vista Way accredited by Crixeo Clinical Trials?

Excell Research, 3998 Vista Way has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Excell Research, 3998 Vista Way?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.